SEARCH  web site
COMPANIES
Discover the reality of companies and brands !
List by name, country, industry, manager, or updated this month, by topic:
WHO ARE WE? - HELP - BOOKSTORE
CONTACT T&C BY EMAIL OR WITH SKYPE Skype Me™!
SHOP LOCAL, ETHICAL AND AT THE BEST PRICE WITH Ethishop
 
 en español  en français  in italiano
translate in arabic chinese dutch german japanese korean russian

Home (12997 companies) > United States of America (2564 companies) > Pharmaceuticals (88 companies) >



Amgen, Inc.


Headquarters location: One Amgen Center Drive Thousand Oaks, CA 91320United States of AmericaTel. 805-447-1000 Job offers, investor relations: www.amgen.com Email: investor.relations@amgen.com Stock: AMGN


Amgen belongs to

shareholder
country     %
source

Amgen owns

subsidiary
country     %
source
Immunex United States of America100Les Echos

Brands

name
items photo compare the prices
AbgenixSee the photo of: AbgenixEthishop
Alantos PharmaceuticalsSee the photo of: Alantos PharmaceuticalsEthishop
AmgenSee the photo of: AmgenEthishop
AranespSee the photo of: AranespEthishop
EnbrelSee the photo of: EnbrelEthishop
EPOSee the photo of: EPOEthishop
EpogenSee the photo of: EpogenEthishop
G-CSF (Neupogen)See the photo of: G-CSF (Neupogen)Ethishop
IlypsaSee the photo of: IlypsaEthishop
NeulastaSee the photo of: NeulastaEthishop
PanitumumabSee the photo of: PanitumumabEthishop
TularikSee the photo of: TularikEthishop
Shop local, ethical and at the best price on Ethishop !

« ETHICAL » RATING OF AMGEN , group and subsidiaries [?]
14%
Job: 14% of company's jobs cut since 1998
1
Delinquency: 1 act(s) of financial or trade delinquency
5
Tax haven, secret bank account, shell companies: operates in 5 offshore financial center(s)
12
Sales: more than 12 billion(s) dollars/euros in annual sales
7
Net profit: more than 7 billion(s) dollars/euros in cumulated net profit since 1998
1054
Top management: earns 1054 times the median income in the United States (32000 US$/year)
3
Influence: 3 act(s) of direct corruption or lobbying

Relevance: business & market share

year
business
source
2006Amgen is the world's tenth-largest pharmaceutical group.Les Echos
2004Largest biotechnology group in the world.Les Echos

World locations & Manufacturing

country incentive : address & contact : production type
source
Barbados Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen Sales Corporation :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 8 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 7 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 6 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 5 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 4 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 3 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development 2 Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Clinical Development Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen (Bermuda) Manufacturing Ltd :
Hong-Kong Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen Greater China Ltd :
Ireland Offshore finance, secret bank account, tax haven, shell companies or free zone(s) : usine, 1100 emplois Les Echos
Switzerland Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Amgen AG :

Amgen is managed by

year name
photo position; compensation
source
2006Morrow, Georges
See the photo of: Morrow, Georges Vice-president; salary: 2.69 million US$; stock-options: 6.92 million US$;
2005Danula, Richard D
See the photo of: Danula, Richard D Chief Financial Officer; salary: 1.98 million US$; stock-options: 3.46 million US$;
2005Sharer, Kevin W
See the photo of: Sharer, Kevin W Chief Executive Officer; salary: 5.89 million US$; stock-options: 27.87 million US$;
2000Baltimore, David
See the photo of: Baltimore, David Director;
2000Bowes, William K
See the photo of: Bowes, William K Director;
2000Choate, Jerry D
See the photo of: Choate, Jerry D Director;
2000Falberg, Kathryn E
See the photo of: Falberg, Kathryn E Chief Financial Officer;
2000Gluck, Frederick W
See the photo of: Gluck, Frederick W Director;
2000Johnson, Franklin P
See the photo of: Johnson, Franklin P Director;
2000Lazarus, Steven
See the photo of: Lazarus, Steven Director;
2000Omenn, Gilbert S
See the photo of: Omenn, Gilbert S Director;
2000Rice, Donald B
See the photo of: Rice, Donald B Director;
2000Sharer, Kevin W
See the photo of: Sharer, Kevin W Chief Executive Officer;
1998Binder, Gordon M
See the photo of: Binder, Gordon M Chief Executive Officer; salary: 10.54 million US$;

Made by

year
employees
<>
social impact : country
source
2007
-2600
Internal restructuring: Amgen is cutting 2600 jobs, 14% of its payroll, because lower sales of two blockbuster drugs.: United States of America
Les Echos
2005
16000
2004
14400
2003
12800
2002
10100
2001
7700
2000
7300
1998
5500

Influence

year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington.
1998Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 74 thousand US$ : US President, Congress, Senate translateCenter for.

Financials

yearfinancial misdemeanorsalesincome buybacksource
2006   5billion US$
2005   12.434.02   billion US$
2005   5billion US$Reuters
2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Canadian P.
2004   10.553.15   billion US$Enjeux Les.
2004   5billion US$
2003   8.36-2.54   billion US$
2002   5.52-1.66   billion US$
2001   4.021.12   billion US$
2000   3.631.14   billion US$
1999   3.341.1   billion US$
1999   2billion US$SmartMoney
1998   2.720.86   billion US$
1998   1billion US$SmartMoney

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >


Further investigation
Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal
: present the company activities, improve the ethical rating's accuracy, develop an network of observers.
Name (or ninckname)*
Email
Title*
Link to document online
Information*
Alert me of answers by email * required field
Please copy the antispam code:


The 5 latest validated comments
Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08
Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09
Lehman brothers   Lehman liquidates three funds - Thursday 17 April 2008 at 14h46
All comments

Subscribe - Log in - Log out |
| © T&C 1999-2008